clinic
microbiolog
laboratori
worldwid
histor
reli
phenotyp
method
ie
cultur
biochem
test
detect
identif
character
virul
trait
eg
antibiot
resist
gene
toxin
human
pathogen
howev
limit
implement
molecular
method
human
infecti
diseas
test
rapidli
overcom
allow
clinic
evalu
implement
divers
technolog
expand
diagnost
capabl
advantag
limit
molecular
techniqu
includ
realtim
polymeras
chain
reaction
partial
whole
genom
sequenc
molecular
type
microarray
broadrang
pcr
multiplex
discuss
final
termin
restrict
fragment
length
polymorph
trflp
deep
sequenc
introduc
technolog
clinic
interfac
potenti
dramat
enhanc
abil
diagnos
infecti
diseas
better
defin
epidemiolog
microbi
ecolog
wide
rang
complex
infect
defin
etiolog
agent
infect
facilit
effect
patient
manag
tailor
specif
target
antibiot
therapi
clinic
microbiolog
laboratori
worldwid
histor
reli
phenotyp
method
ie
cultur
biochem
see
front
matter
elsevi
bv
right
reserv
test
detect
identif
character
virul
trait
eg
antibiot
resist
gene
toxin
human
pathogen
howev
limit
implement
molecular
method
human
infecti
diseas
test
rapidli
overcom
allow
clinic
evalu
implement
divers
technolog
expand
diagnost
capabl
molecular
method
increasingli
exploit
diagnos
classic
fastidi
pathogen
sinc
advent
polymeras
chain
reaction
pcr
mulli
faloona
infecti
agent
identifi
larg
character
past
two
decad
use
molecular
method
includ
hepat
c
viru
choo
et
al
tropheryma
whipplei
mycobacterium
genavens
bottger
et
al
bartonella
previous
rochalimaea
hensela
matar
et
al
hantaviru
sin
nombr
viru
chapman
khabbaz
chlamydia
pneumonia
twar
agent
kuo
et
al
herpesviru
huang
et
al
sar
coronaviru
drosten
et
al
ksiazek
et
al
metapneumoviru
mackay
et
al
influenza
renesto
et
al
dawood
et
al
commerci
supplier
steadili
expand
number
molecular
diagnost
assay
infecti
diseas
test
http
wwwfdaorg
despit
continu
advanc
microbi
etiolog
remain
defin
number
case
human
diseas
epidemiolog
clinic
andor
histolog
featur
infect
worldwid
popul
increasingli
put
risk
novel
contagion
particularli
zoonot
agent
bacteri
pathogen
carri
acquir
antimicrobi
resist
gene
church
broad
applic
highli
sensit
molecular
technolog
common
infect
also
reveal
diseas
monomicrobi
previous
thought
rather
due
disord
complex
microbi
commun
human
microbiom
compris
trillion
microbi
cell
outnumb
somat
cell
bodi
least
order
magnitud
savag
suggest
earli
order
properli
appreci
human
biolog
gene
encod
human
genom
must
place
context
million
gene
encod
microbi
counterpart
inhabit
gastrointestin
tract
genitourinari
tract
oral
caviti
nasopharynx
respiratori
tract
skin
davi
human
microbiom
project
design
sequenc
novel
bacteri
refer
genom
entir
collect
microbi
genom
healthi
individu
turnbaugh
et
al
peterson
et
al
vast
number
human
commens
microbi
speci
yet
identifi
character
composit
human
microbiota
uniqu
vari
significantli
bodi
site
recent
studi
show
million
nonredund
gene
fold
greater
human
genom
assembl
distinct
microbi
speci
human
gut
sampl
qin
et
al
divers
human
microbiom
also
affect
environment
factor
diet
host
immun
system
ley
et
al
essenti
role
commens
microorgan
play
human
health
becom
increasingli
recogn
function
involv
normal
develop
nutrit
immun
regul
colon
resist
brook
hooper
mazmanian
et
al
li
et
al
clark
et
al
also
evid
accru
function
capac
human
microbiom
may
alter
patient
obes
chronic
condit
qin
et
al
molecular
method
diagnost
microbiolog
divers
advantag
limit
techniqu
includ
realtim
polymeras
chain
reaction
partial
whole
genom
sequenc
molecular
type
microarray
broad
rang
pcr
multiplex
discuss
final
termin
restrict
fragment
length
polymorph
trflp
deep
sequenc
introduc
technolog
clinic
interfac
potenti
dramat
enhanc
abil
diagnos
infecti
diseas
better
defin
epidemiolog
microbi
ecolog
wide
rang
complex
infect
diagnosi
infecti
diseas
use
pcr
involv
target
amplif
method
often
nucleic
acid
sequenc
analysi
amplicon
unlik
phenotyp
characterist
may
variabl
molecular
amplif
method
take
advantag
use
stabl
genotyp
characterist
anoth
major
diagnost
advantag
pcr
detect
nucleic
acid
requir
labor
intens
cultiv
microbi
biomass
bacteri
genom
provid
variabl
region
speci
identif
virul
factor
toxin
loci
use
defin
pathogen
organ
addit
standard
pcr
complet
genom
sequenc
greatli
facilit
rapid
develop
molecular
identif
method
pathogen
detect
includ
nucleic
acid
hybrid
probe
procop
ligas
chain
reaction
drancourt
et
al
stranddisplac
amplif
sda
walker
et
al
b
transcriptionbas
amplif
ta
tma
nasba
kwoh
et
al
compton
fahi
et
al
loopmedi
isotherm
amplif
lamp
notomi
et
al
enorm
amount
nucleic
acid
sequenc
data
human
pathogen
enhanc
diagnost
capabl
sequencedbas
identif
genotyp
method
common
uncommon
microorgan
fournier
raoult
despit
develop
altern
amplif
technolog
pcr
remain
wide
use
method
research
diagnost
laboratori
pathogen
detect
lisbi
fig
principl
realtim
pcr
probe
illustr
heid
et
al
mothersh
whitney
procop
convent
pcr
assay
design
singl
target
detect
broadli
util
larg
diagnost
microbiolog
laboratori
past
year
lisbi
target
human
pathogen
base
specif
loci
taxonom
identif
import
phenotyp
trait
antimicrobi
resist
determin
virul
factor
mothersh
whitney
realtim
pcr
detect
use
probe
illustr
fig
heid
et
al
target
detect
real
time
seal
pcr
plate
postpcr
process
requir
whitcomb
et
al
therefor
risk
falseposit
result
due
amplicon
carryov
substanti
decreas
compar
convent
pcr
barken
et
al
addit
realtim
pcr
format
offer
option
melt
curv
analysi
amplicon
distinguish
nonspecif
product
primerdim
mackay
tevfik
dorak
perform
realtim
pcr
assay
therefor
increas
sensit
reliabl
report
result
compar
obtain
convent
pcr
espi
et
al
mothersh
whitney
procop
realtim
pcr
assay
design
allow
detect
simultan
quantif
pcr
product
wide
dynam
rang
quantit
linear
import
requir
mani
diagnost
applic
croagh
et
al
itakura
et
al
luft
et
al
realtim
pcr
assay
amen
autom
detect
assay
run
complet
clinic
laboratori
set
shorter
time
convent
pcr
therefor
provid
rapid
test
cycl
turnaround
time
realtim
pcr
truli
becom
walkaway
molecular
test
clinic
laboratori
set
despit
benefit
cost
limit
implement
smaller
laboratori
limit
resourc
instrument
cost
price
singl
realtim
pcr
reaction
includ
dna
extract
three
time
cost
convent
pcr
mothersh
whitney
commerci
avail
pcr
assay
kit
initi
focuss
detect
sexual
transmit
infect
bloodborn
virus
convers
fluoresc
base
method
result
rapidli
expand
menu
human
diagnost
realtim
pcr
assay
develop
inhous
well
commerci
http
wwwfdaorg
renesto
et
al
edberg
et
al
heyman
et
al
scott
et
al
dien
et
al
hadfield
et
al
kruttgen
et
al
lehour
et
al
luo
et
al
luong
et
al
nakauchi
et
al
polley
et
al
thurman
et
al
touinssi
et
al
wilson
et
al
wolff
et
al
xu
et
al
mani
realtim
pcr
assay
detect
pathogen
current
develop
includ
detect
vancomycinresist
enterococci
clostridium
difficil
near
futur
clinic
laboratori
abl
perform
mani
differ
type
monoplex
multiplex
realtim
pcr
assay
screen
detect
nosocomi
surveil
autom
instrument
system
akin
perform
highvolum
infecti
diseas
serolog
test
autom
instrument
perform
enzym
immunoassay
test
nucleic
acid
sequenc
emerg
import
tool
pathogen
identif
discoveri
identif
human
pathogen
partial
whole
gene
sequenc
wide
adopt
clinic
microbiolog
laboratori
even
decad
ago
due
labor
expens
bring
technolog
inhous
lack
standard
method
conduct
analys
interpret
result
prior
dna
target
sequenc
primarili
use
identif
organ
difficult
identifi
use
convent
phenotyp
method
recov
cultiv
woo
et
al
pareek
et
al
dna
target
sequenc
rapid
identif
bacteri
viral
fungal
pathogen
sinc
increasingli
implement
routin
procedur
mani
clinic
laboratori
last
decad
dna
sequenc
technolog
improv
throughput
capabl
cost
import
guidelin
publish
provid
interpret
criteria
identif
wide
rang
clinic
import
bacteria
fungi
speci
genu
level
petti
et
al
commerci
softwar
avail
provid
qualiti
assur
databas
known
bacteri
fungal
sequenc
human
pathogen
smartgen
idn
lausann
switzerland
simmon
et
al
diagnost
laboratori
also
perform
sequenc
analysi
viral
cdna
gener
revers
transcript
fournier
raoult
sangerbas
sequenc
technolog
remain
commonli
use
method
although
newer
nonelectrophoresi
method
ie
pyrosequenc
iontorr
sequenc
increasingli
use
clinic
applic
improv
effici
decreas
cost
discuss
later
dna
target
sequenc
routin
identif
util
conserv
gene
bacteria
fungi
wide
use
taxonom
purpos
bottger
doolittl
atkin
clark
petti
bacteria
rrna
gene
intergen
region
commonli
use
taxonom
purpos
gene
univers
present
minim
affect
horizont
gene
transfer
contain
hypervari
region
flank
high
sequenc
conserv
characterist
made
rrna
gene
wide
use
region
bacteri
taxonomi
identif
doolittl
sequenc
inform
obtain
portion
rrna
gene
often
provid
suffici
data
identif
purpos
petti
woo
et
al
much
data
public
databas
also
correspond
region
rrna
gene
eg
genbank
occasion
entir
bp
region
requir
distinguish
particular
taxa
strain
altern
dna
gene
target
may
also
interrog
speci
may
share
rrna
sequenc
ident
facklam
janda
abbott
altern
gene
target
speciat
use
includ
reca
rpob
tuf
gyra
gyrb
famili
protein
function
conserv
region
interven
variabl
fungi
eukaryot
rrna
gene
complex
consist
four
ribosom
gene
small
subunit
larg
subunit
gene
within
region
intern
transcrib
spacer
white
et
al
approxim
bp
region
subunit
kurtzman
robnett
phylogenet
variabl
region
wide
use
fungal
taxonomi
identif
atkin
clark
petti
et
al
sever
investig
compar
perform
rrna
gene
fungal
gene
sequenc
convent
phenotyp
method
commerci
autom
system
identif
human
pathogen
overal
dna
target
sequenc
provid
somewhat
higher
rate
speci
identif
phenotyp
method
accuraci
depend
group
bacteria
studi
criteria
use
defin
speci
bosshard
et
al
bosshard
et
al
bosshard
et
al
heiken
et
al
simmon
et
al
simmon
et
al
rrna
gene
target
howev
discrimin
mani
speci
within
enterobacteriacea
close
relat
staphylococcu
enterococcu
streptococcu
speci
petti
petti
et
al
c
similarli
fungal
sequenc
use
gene
region
provid
excel
identif
compar
phenotyp
method
allow
much
rapid
identif
nonsporul
mold
rare
yeast
difficult
identifi
use
classic
method
ciardo
et
al
ciardo
et
al
borman
et
al
borman
et
al
pounder
et
al
molecular
type
bacteri
isol
requir
infecti
diseas
epidemiolog
surveil
detect
laboratori
cross
contamin
distinguish
relaps
reinfect
surveil
infecti
outbreak
van
belkum
et
al
molecular
type
therefor
crucial
sourc
track
epidemiolog
van
belkum
et
al
fournier
raoult
van
belkum
colleagu
publish
comprehens
review
guidelin
valid
applic
molecular
type
method
use
bacteri
epidemiolog
van
belkum
et
al
among
nonsequencebas
method
pulsedfield
gel
electrophoresi
pfge
separ
macrorestrict
dna
fragment
gold
standard
techniqu
use
clinic
laboratori
examin
molecular
related
bacteri
isol
well
yeast
fungi
beadl
et
al
provid
pfge
method
interpret
care
standard
given
microorgan
method
robust
reliabl
intraand
interlaboratori
reproduc
goer
similar
dna
fragmentbas
method
also
develop
use
clinic
analys
includ
restrict
endonucleas
fingerprint
analysi
rea
falk
et
al
plasmid
type
farrar
mayer
nicol
et
al
ribotyp
thomsoncart
et
al
pcr
fingerprint
welsh
mcclelland
restrict
fragment
length
polymorph
rflp
goh
et
al
metzgar
et
al
amplifi
fragment
length
polymorph
aflp
vo
et
al
meudt
clark
multilocu
variabl
number
tandem
repeat
analysi
mlva
anoth
pcrbase
method
use
determin
number
length
variabl
number
tandem
repeat
vntr
present
genom
due
slip
mispair
sever
mlva
system
develop
interpret
varieti
speci
van
belkum
et
al
multicentr
studi
done
francoi
et
al
kremer
et
al
due
dedic
expertis
labor
special
equip
need
perform
pfge
fragmentbas
method
clinic
laboratori
increasingli
turn
rapid
semiautom
pcrbase
sequencebas
method
perform
either
rapid
initi
routin
genotyp
analys
diversilab
system
perform
semiautom
repetitivepcr
analysi
heali
et
al
good
excel
agreement
compar
sever
type
method
distinguish
sever
differ
type
microorgan
fluit
et
al
overdevest
et
al
deplano
et
al
includ
methicillinresist
staphylococcu
aureu
mrsa
tenov
et
al
baboue
et
al
church
et
al
vancomycinresist
enterococcu
chuang
et
al
bourdon
et
al
commonli
encount
dermatophyt
dematophyt
candida
fungi
pounder
et
al
pounder
et
al
wise
et
al
hansen
et
al
method
also
use
genotyp
acinetobact
baumanii
outbreak
strain
extendedspectrum
blactamas
produc
escherichia
coli
klebsiella
pneumonia
isol
pitout
et
al
brolund
et
al
higgin
et
al
semiautom
reppcr
diversilab
howev
alway
provid
discrimin
power
pfge
type
method
baboue
et
al
bourdon
et
al
brolund
et
al
chuang
et
al
church
et
al
b
tenov
et
al
recogn
limit
semiautom
platform
diversilab
may
nevertheless
use
tool
rapid
identif
nosocomi
outbreak
depend
type
bacteria
involv
use
parallel
confirmatori
analysi
greater
discriminatori
power
sever
sequencebas
genotyp
method
use
infect
surveil
track
strain
evolut
within
given
geograph
locat
singlelocu
sequenc
type
slst
use
dna
sequenc
obtain
highli
variabl
singl
genet
locu
provid
strain
discrimin
genotyp
streptococcu
pyogen
use
emm
locu
reli
sequenc
bp
code
ntermin
protein
simmon
et
al
interestingli
slst
type
pyogen
identifi
twice
mani
mtype
previous
shown
use
antisera
http
wwwcdcgovncidodbiotechstrepstrepindexhtm
mani
clinic
laboratori
also
reli
slst
type
aureu
accord
spa
gene
encod
protein
rapid
sequenc
determin
spatyp
may
autom
develop
dedic
softwar
sequenc
interpret
harmsen
et
al
b
clinic
appeal
slst
system
one
develop
aureu
abil
use
exist
equip
mani
laboratori
autom
sequenc
excel
site
site
reproduc
sequencebas
genotyp
method
incorpor
genom
sequenc
data
design
base
genom
sequenc
includ
singlenucleotid
polymorph
snp
type
multilocu
sequenc
type
mlst
maiden
et
al
chalon
et
al
hayford
et
al
lilliebridg
et
al
van
gent
et
al
howev
expens
labori
complex
method
mainli
use
specif
populationbas
microorgan
divers
populationbas
epidemiolog
studi
current
wide
perform
diagnost
techniqu
identif
singl
nucleotid
polymorph
snp
base
identifi
point
mutat
variou
genom
loci
use
genotyp
character
sever
bacteri
pathogen
http
wwwncbinlmnihgovproject
snp
mlst
base
determin
dna
sequenc
variat
sever
housekeep
gene
proven
taxonom
util
larg
due
standard
interpret
public
avail
softwar
ie
eburst
access
databas
http
wwwmlstnet
multi
spacer
type
mst
reli
combin
variabl
intergen
spacer
strain
report
use
method
restrict
rickettsia
isol
fournier
raoult
clinic
microbiolog
laboratori
use
molecular
method
enhanc
detect
pathogen
critic
clinic
situat
wherebi
phenotyp
method
fail
identifi
etiolog
agent
usual
pathogen
fastidi
uncultiv
andor
patient
given
empir
antibiot
coverag
prior
collect
submiss
clinic
specimen
organ
may
cultivat
later
situat
present
low
number
phenotyp
method
sensit
enough
detect
current
two
commonli
use
method
detect
organ
includ
microarraybas
assay
univers
broadrang
pcr
util
speciesspecif
hybrid
probe
sequenc
electromass
spectrometri
subsequ
analysi
product
nextgener
sequenc
technolog
may
also
routin
employ
futur
pathogen
detect
discoveri
clinic
laboratori
although
univers
broadrang
rrna
gene
pcr
origin
develop
determin
microbi
commun
divers
within
complex
bacteri
popul
extrem
environ
subsequ
use
pathogen
detect
convent
bacteriolog
techniqu
fail
produc
diagnost
result
sontakk
et
al
broadrang
pcr
offer
import
clinic
benefit
analysi
critic
cultureneg
sampl
detect
bacteri
nucleic
acid
present
sampl
target
conserv
bacteri
sequenc
describ
section
nucleic
acid
sequenc
amplicon
gener
broadrang
pcr
allow
identif
organ
comparison
known
sequenc
deposit
genbank
databas
drancourt
et
al
janda
abbott
petti
previous
uncharacter
microb
novel
pathogen
may
also
detect
univers
natur
primersprob
high
sensit
detect
presenc
low
copi
number
target
bottger
relman
falkow
greisen
et
al
monstein
et
al
drancourt
et
al
mothersh
whitney
procop
sever
investig
initi
use
amplif
conserv
region
bacteri
ribosom
rna
amplicon
sequenc
identifi
human
pathogen
bottger
wilson
et
al
subsequ
broadrang
pcr
extens
use
nonselect
detect
bacteri
dna
clinic
sampl
monstein
et
al
corless
et
al
nadkarni
et
al
nikkari
et
al
harri
hartley
saravolatz
et
al
xu
et
al
ott
et
al
jordan
et
al
zucol
et
al
fenollar
raoult
rosey
et
al
reiernilsen
et
al
chang
et
al
rather
perform
multipl
monoplex
pcr
assay
given
sampl
broadrang
assay
design
singl
clinic
sampl
simultan
screen
multipl
organ
ie
bacteri
speci
howev
amplicon
may
requir
clone
prior
sequenc
order
get
accur
result
tradit
sangerbas
method
due
potenti
mix
natur
amplifi
product
grahn
et
al
approach
success
appli
clinic
sampl
normal
steril
site
diagnos
invas
bacteri
fungal
infect
includ
cultureneg
mening
pneumonia
endocard
increasingli
approach
also
use
identifi
put
pathogen
number
inflammatori
diseas
detect
known
pathogen
easili
diagnos
use
standard
method
tropheryma
whippelii
identifi
caus
whippl
diseas
use
broadrang
molecular
pcr
lepidi
et
al
helicobact
pylori
caus
peptic
ulcer
diseas
found
domin
microbiota
human
stomach
use
broadrang
molecular
analysi
bik
et
al
broadrang
pcr
also
use
detect
clinic
relev
chlamydia
spp
infect
human
anim
goldschmidt
et
al
signific
advantag
realtim
broadrang
pcr
assay
abil
quantifi
bacteri
load
sampl
higher
analyt
sensit
compar
convent
pcr
zucol
et
al
ammann
et
al
fenollar
et
al
minim
detect
limit
convent
broadrang
pcr
determin
rang
ten
cfu
cfu
equival
per
pcr
harri
hartley
wherea
report
detect
limit
realtim
broadrang
assay
lower
improv
sensit
zucol
colleagu
develop
broadrang
realtim
pcr
assay
method
abl
detect
cfu
water
per
reaction
test
clinic
sampl
zucol
et
al
overal
sensit
detect
limit
broadrang
pcr
assay
may
also
influenc
sever
factor
includ
prior
cultur
enrich
sampl
use
good
molecular
laboratori
practic
decontamin
procedur
extract
method
choic
univers
primer
probe
assay
cycl
time
melt
temperatur
concentr
amplifi
product
prior
sequenc
appropri
use
control
throughout
procedur
harri
hartley
sontakk
et
al
sever
studi
shown
substanti
increas
sensit
broadrang
pcr
reaction
clinic
sampl
undergo
prior
cultur
enrich
broth
shell
vial
rather
direct
plate
prior
molecular
analysi
harri
hartley
gouriet
et
al
saglani
et
al
enrich
cultur
pediatr
fluid
tissu
sampl
broth
medium
prior
rdna
pcr
identifi
sever
pathogen
sampl
previous
detect
primari
plate
direct
pcr
extract
dna
sampl
harri
hartley
saglani
colleagu
also
perform
broadrang
pcr
pleural
fluid
sampl
children
empyema
detect
bacteri
dna
sampl
follow
enrich
cultur
versu
direct
plate
saglani
et
al
cultureenrich
parallel
broadrang
pcr
also
shown
effect
mean
bacteri
recoveri
identif
cystic
fibrosi
sputum
sibley
et
al
shell
vial
cultur
also
use
enrich
techniqu
growth
fastidi
previous
uncharacter
microorgan
clinic
sampl
gouriet
et
al
human
embryon
lung
fibroblast
human
endotheli
cell
line
use
often
follow
broadrang
pcr
sequenc
identifi
organ
initi
clinic
evalu
broadrang
pcr
use
convent
method
howev
dna
contamin
sourc
includ
environment
commens
organ
pcr
reagent
includ
taq
polymeras
even
dispos
identifi
major
concern
broadrang
pcr
due
sensit
assay
corless
et
al
vandecasteel
et
al
mohammadi
et
al
chang
et
al
univers
primer
probe
target
rrna
gene
therefor
recent
adapt
realtim
broadrang
pcr
order
minim
problem
kobayashi
et
al
goldschmidt
et
al
zucol
et
al
deutch
et
al
schabereitergurtn
et
al
univers
rrna
gene
target
high
sensit
pcr
limit
due
fals
posit
test
result
analyz
clinic
sampl
even
small
amount
bacteri
dna
contamin
either
within
clinic
sampl
introduc
part
molecular
procedur
may
result
fals
posit
broadrang
pcr
result
result
difficult
interpret
amplif
one
common
commens
organ
investig
outlin
sever
sourc
bacteri
dna
contamin
may
occur
sampl
collect
nucleic
acid
extract
pcr
analysi
step
millar
et
al
millar
et
al
vandecasteel
et
al
fenollar
et
al
fenollar
et
al
despit
clinic
laboratori
standard
oper
procedur
collect
type
clinic
sampl
contamin
commens
organ
remain
problemat
mani
specimen
type
blake
doherti
dhillon
et
al
marlow
et
al
patton
schmitt
ishikawa
et
al
dnase
restrict
enzym
may
also
use
decontamin
pcr
reaction
mixtur
millar
et
al
vandecasteel
et
al
broadrang
pcr
assay
perform
use
good
molecular
laboratori
practic
previous
outlin
mitchel
et
al
addit
critic
human
dna
amplif
control
well
posit
neg
control
tanner
et
al
millar
et
al
bosshard
et
al
greub
et
al
fenollar
et
al
includ
sampl
extract
carri
throughout
procedur
neg
control
consist
neg
sampl
control
ie
aliquot
known
neg
clinic
sampl
blood
person
without
bacteraemia
neg
reaction
mixtur
control
ie
contain
reagent
clinic
sampl
extract
order
detect
reagent
contamin
commerci
reagent
may
also
sourc
bacteri
contamin
may
need
steril
use
filtrat
method
prior
use
muhl
et
al
chang
et
al
current
univers
dna
extract
protocol
effect
gramneg
gramposit
bacteria
extract
method
impact
analyt
sensit
assay
prior
studi
broadspectrum
pcr
use
enzym
treatment
lysozym
proteinas
k
freez
thaw
boil
mechan
disrupt
commerci
method
ie
qiamp
blood
kit
qiagen
autom
instrument
combin
method
dna
extract
schuurman
et
al
zucol
et
al
rosey
et
al
fenollar
et
al
zucol
colleagu
determin
analyt
sensit
broadrang
rtpcr
base
assay
employ
one
three
differ
genom
dna
extract
protocol
combin
one
three
differ
primer
pair
target
rrna
gene
detect
panel
bacteri
speci
zucol
et
al
dna
extract
protocol
use
lysozym
lysostaphin
proteinas
k
follow
pcr
amplif
use
primer
bp
product
result
best
overal
sensit
strain
detect
low
concentr
zucol
et
al
select
primer
probe
broadrang
pcr
assay
also
effect
analyt
sensit
primer
target
rrna
gene
use
assay
also
target
rrna
gene
greisen
et
al
outlin
baker
et
al
possibl
develop
rrna
gene
primer
set
entir
univers
therefor
differ
conserv
region
within
rrna
gene
variou
primer
sequenc
employ
analysi
human
clinic
specimen
greisen
et
al
baker
et
al
target
loci
primer
sequenc
impact
taxonom
assign
addit
analysi
exist
primer
set
demonstr
environment
organ
within
archaea
eukarya
also
detect
anoth
limit
approach
definit
identif
alway
possibl
due
lack
qualiti
data
public
databas
well
insuffici
sequenc
diverg
within
rrna
gene
sequenc
certain
taxonom
group
petti
petti
et
al
simmon
et
al
despit
limit
diagnost
util
broad
rang
rdna
pcr
evalu
varieti
clinic
condit
includ
endocard
mening
bone
joint
infect
endophthalm
fenollar
raoult
sontakk
et
al
method
also
use
determin
caus
infect
pediatr
patient
fever
neutropenia
jordan
et
al
ammann
et
al
reiernilsen
et
al
cultureneg
intracerebr
abscess
petti
et
al
well
determin
caus
death
patient
unexplain
mortal
critic
ill
nikkari
et
al
implement
broadrang
pcr
detect
differenti
bacteria
heart
valv
specimen
substanti
improv
diagnosi
cultureneg
endocard
marin
et
al
although
heart
valv
cultur
remain
part
duke
classif
scheme
diagnosi
infecti
endocard
poor
sensit
specif
led
sever
investig
recommend
cultur
test
replac
broadrang
pcr
major
diagnost
criterion
much
higher
sensit
rang
specif
sever
studi
document
reliabl
broadrang
pcr
detect
bacteria
excis
heart
valv
assay
increasingli
use
conjunct
blood
cultur
determin
microbi
aetiolog
blood
cultureposit
neg
endocard
case
moor
et
al
bosshard
et
al
lepidi
et
al
lepidi
et
al
breitkopf
et
al
greub
et
al
houpikian
raoult
raoult
et
al
rice
madico
roveri
et
al
marin
et
al
dreier
et
al
munoz
et
al
voldstedlund
et
al
tang
fournier
et
al
caram
et
al
broadrang
rdna
gene
pcr
heart
valv
tissu
allow
diagnosi
unusu
caus
agent
cultureneg
endocard
includ
cardiobacterium
homini
mueller
et
al
bartonella
quintana
houpikian
raoult
dreier
et
al
interpret
broadrang
pcr
result
correl
clinic
pictur
due
potenti
dna
contamin
sourc
posit
broadrang
pcr
result
correl
patient
clinic
histori
examin
find
along
result
pertin
diagnost
test
inform
determin
likelihood
particular
diseas
exampl
case
cerebrospin
fluid
csf
sampl
test
posit
broadrang
pcr
bacteri
mening
pathogen
patient
clinic
present
csf
test
result
ie
csf
glucos
protein
cell
count
cultur
consist
diagnosi
acut
mening
strength
also
ad
broadrang
result
detect
rare
unusu
pathogen
microorgan
detect
longitudin
sampl
multipl
sampl
kind
sever
patient
sever
differ
specimen
type
interpret
presenc
common
specimencultur
contamin
broadrang
pcr
may
particularli
difficult
isol
may
also
potenti
caus
infect
ie
streptococcu
viridan
sp
coagulas
neg
staphylococci
clinic
relev
bacteri
dna
detect
may
also
indic
activ
infect
patient
receiv
prior
antibiot
treatment
sinc
broadrang
pcr
assay
also
detect
nucleic
acid
nonviabl
cell
broadrang
pcr
studi
detect
bacteri
dna
heart
valv
tissu
clearli
demonstr
bacteria
slowli
clear
tissu
despit
antibiot
therapi
molecular
assay
result
interpret
caution
bacteria
may
longer
viabl
roveri
colleagu
show
bacteri
dna
found
heart
valv
often
patient
underw
heart
valv
replac
still
antibiot
therapi
versu
surgeri
complet
antibiot
treatment
p
roveri
et
al
presenc
bacteri
dna
howev
highli
correl
presenc
histolog
lesion
p
presenc
bacteria
tissu
gram
stain
p
new
commerci
highthroughput
bioidentif
system
plexid
abbott
molecular
recent
becom
avail
combin
broadrang
pcr
use
sever
gene
target
tabl
product
detect
analysi
electrospray
ioniz
mass
spectrometri
pcresim
hofstadl
et
al
baldwin
et
al
show
great
promis
identifi
broad
rang
pathogen
without
prior
knowledg
pathogen
nucleic
acid
sequenc
http
usplexidcomstystemoverview
ecker
et
al
baldwin
et
al
pcresim
also
provid
result
includ
inform
organ
genotyp
resist
virul
profil
although
current
restrict
epidemiolog
genom
studi
pathogen
discoveri
technolog
may
major
diagnost
advantag
abl
provid
detect
identif
character
broad
rang
pathogen
directli
clinic
specimen
instrument
also
potenti
process
sampl
h
period
pcresim
far
limit
clinic
evalu
sever
recent
publish
studi
demonstr
potenti
rang
human
diagnost
applic
rapid
detect
bacteraemia
identif
type
wide
rang
pathogen
ie
aureu
candida
spp
mycobacterium
spp
erlichia
spp
influenza
respiratori
virus
panorthopoxvirus
eshoo
et
al
eshoo
et
al
hall
et
al
wolk
et
al
deyd
et
al
metzgar
et
al
chen
et
al
b
gu
et
al
kaleta
et
al
massir
et
al
wang
et
al
howev
valid
pcresim
clinic
laboratori
need
perform
standard
procedur
order
demonstr
role
system
potenti
replac
identif
method
current
faster
fast
much
less
expens
perform
microarray
use
highthroughput
largescal
screen
system
allow
simultan
identif
character
larg
number
sever
hundr
thousand
allel
interest
microarray
therefor
power
tool
greater
capac
compar
molecular
method
ie
realtim
pcr
analyz
small
number
target
microarraybas
genotyp
potenti
identifi
new
gene
includ
sequenc
deriv
relat
bacteria
identifi
polymorph
detect
oligonucleotid
hybrid
miller
tang
dna
microarray
also
use
diagnos
infect
identif
pathogen
simultan
detect
drugresist
virulenceassoci
trait
isol
bager
et
al
technic
detail
variou
microarray
configur
includ
probe
length
synthesi
number
possibl
featur
ie
densiti
microarray
solidsurfac
use
previous
outlin
detail
bager
et
al
miller
tang
briefli
microarray
consist
million
predesign
develop
oligonucleotid
probe
ie
consist
either
dsdna
pcr
amplicon
bp
known
genet
sequenc
shotgun
librari
clone
cdna
specif
bound
immobil
solidsurfac
support
array
target
nucleic
acid
extract
pathogen
clinic
specimen
interest
fluoresc
label
subsequ
hybrid
probe
matrix
microarray
success
hybrid
event
label
target
molecul
immobil
probe
oligonucleotid
creat
increas
fluoresc
intens
background
level
measur
use
either
fluoresc
scanner
flow
cytomet
larg
amount
complex
data
gener
microarray
assay
analyz
use
varieti
method
sophist
bioinformat
algorithm
zhang
et
al
kaewpongsri
et
al
loew
nelson
manufactur
genom
advanc
allow
expand
develop
sever
commerci
microarray
format
includ
solidsupport
highdens
beadbead
electron
liquid
suspens
beadbas
array
perform
analyz
use
bioinformat
softwar
autom
system
miller
tang
tradit
probe
print
onto
glass
slide
commerci
system
reli
sever
techniqu
microarray
product
spatial
matrix
arrang
includ
situ
synthesi
oligonucleotid
onto
surfac
quartz
wafer
genechip
affymetrix
ii
highdens
bead
array
sam
sentrix
beadchip
illumina
san
diego
ca
iii
lowdens
electron
array
use
microelectron
devic
nanochip
nanogen
san
diego
ca
iv
liquidbas
suspens
beadbas
array
use
color
microspher
solid
support
appli
probe
luminex
corp
austin
tx
microarray
theoret
appear
ideal
technolog
clinic
microbiolog
applic
pathogen
could
detect
identifi
also
genotyp
profil
determin
antimicrobi
resist
virul
trait
use
singl
test
although
microarray
use
complex
human
genet
applic
wide
use
clinic
microbiolog
laboratori
increasingli
implement
simultan
detect
identif
genotyp
import
viral
infect
major
factor
limit
implement
print
commerci
microarray
assay
format
clinic
microbiolog
set
outlin
tabl
miller
tang
although
sever
commerci
supplier
develop
infecti
diseas
microarray
research
purpos
manufactur
customerspecifi
assay
commerci
assay
use
diagnost
detect
larg
panel
respiratori
virus
petti
hillyard
nolt
et
al
pabbataju
et
al
merant
et
al
includ
fdaapprov
xtag
respiratori
viral
panel
fast
assay
ie
eight
differ
respiratori
virus
includ
strain
influenza
b
liquid
suspens
beadbas
format
luminex
krunic
et
al
merant
et
al
pabbaraju
et
al
luminex
molecular
diagnost
toronto
ont
although
commerci
nanochip
nanogen
microarray
panel
test
previous
develop
infect
test
human
papilloma
viru
transplant
bacteri
pneumonia
infect
control
tuberculosi
gastrointestin
panel
compani
discontinu
microarray
busi
howev
multitud
clinic
applic
develop
liquid
suspens
beadbas
microarray
luminex
method
like
success
develop
commerci
select
diagnost
multiplex
panel
test
eg
viral
enceph
panel
antibiot
resist
panel
etc
low
middledens
microarray
assay
also
increasingli
use
diagnost
test
epidemiolog
investig
date
microarray
techniqu
wide
appli
detect
identif
genotyp
human
papilloma
virus
hpv
known
caus
cervic
dysplasia
cancer
cervix
site
hwang
et
al
oh
et
al
albrecht
et
al
gheit
et
al
klug
et
al
ermel
et
al
eklund
et
al
schopp
et
al
cho
et
al
current
identifi
genotyp
hpv
genit
hpv
type
assign
either
oncogen
highrisk
nononcogen
lowrisk
categori
base
detect
cervic
cancer
munoz
et
al
worldwid
hpv
type
shown
caus
major
cervic
cancer
approxim
half
high
grade
precancer
lesion
quarter
low
grade
lesion
wherea
lowrisk
hpv
type
caus
genit
wart
low
grade
cervic
lesion
munoz
et
al
li
et
al
epidemiolog
surveil
highrisk
hpv
genotyp
therefor
import
clinic
care
also
vaccin
develop
one
earliest
studi
clinic
efficaci
hpv
oligonucleotid
microarray
detect
type
highrisk
hpv
seven
type
lowrisk
hpv
variou
histolog
cervic
lesion
show
highli
compar
method
pcrrflp
analysi
hpv
dna
detect
cervic
sampl
pcrrflp
compar
hpv
microarray
method
respect
hwang
et
al
subsequ
studi
compar
sever
commerci
hpv
detect
genotyp
assay
highlight
differ
perform
regard
typespecif
detect
rate
variou
hpv
genotyp
klug
et
al
ermel
et
al
eklund
et
al
schopp
et
al
cho
et
al
papillocheck
genetel
inhous
hpv
detect
data
set
respect
less
common
hpv
type
detect
less
data
set
asid
nondetect
specif
hpv
type
falseposit
hpv
genotyp
result
occur
two
commerci
test
also
report
twentyeight
data
set
also
consid
nonprofici
although
sensit
hpv
test
detect
cervic
screen
program
need
high
less
commonli
encount
oncogen
hpv
type
clinic
laboratori
need
know
limit
variou
microarray
method
follow
recent
publish
guidelin
evalu
test
implement
meijer
et
al
sever
evalu
also
done
microarray
simultan
assess
larg
number
microbi
gene
target
order
detect
identifi
pathogen
clinic
sampl
howev
sensit
microarray
assay
detect
identif
pathogen
clinic
sampl
highli
depend
target
gene
enhanc
specif
microbi
gene
amplif
analysi
array
either
broadrang
multiplex
pcr
commonli
use
target
conserv
region
within
bacteri
fungal
intergen
transcrib
spacer
itss
rrna
gene
prior
microarray
analysi
downstream
pcr
product
instead
reli
dna
target
sequenc
rood
et
al
earli
applic
approach
panel
detect
predomin
human
intestin
bacteri
pathogen
clinic
stool
sampl
blyn
et
al
ecker
et
al
clinic
applic
userdefin
microarray
includ
rapid
detect
character
methicillinresist
aureu
mrsa
koessler
et
al
detect
antimicrobi
resist
gene
bager
et
al
microbi
type
bacteri
enterocol
pathogen
volokhov
et
al
fitzgerald
et
al
character
properti
pathogen
microbi
commun
new
frontier
clinic
microbiolog
studi
human
microbiom
demonstr
far
need
reliabl
access
core
facil
dust
humid
temperatur
control
littl
supervis
qualiti
control
manufactur
requir
extens
inhous
probe
design
manufactur
requir
expens
assay
valid
requir
access
inhous
bioinformat
analyz
assess
qualiti
data
inflex
chang
assay
probe
requir
nonconduc
userdefin
develop
except
agil
insitu
synthes
oligonucleotid
array
genechip
affymetrix
customassay
product
autom
expens
highdens
spot
probe
per
assay
complex
manufactur
probe
chemic
synthes
directli
quartz
wafer
electron
nanochip
nanogen
electr
field
promot
activ
hybrid
nucleic
acid
onto
microelectron
devic
lowdens
maximum
adequ
diagnost
panel
assay
less
expens
highdens
format
allow
flexibl
test
multipl
target
singl
sampl
multipl
sampl
microarray
cartridg
commerci
avail
product
discontinu
liquidbas
suspens
beadbas
array
probe
univers
sequenc
tag
attach
spectral
uniqu
microspher
bead
hybrid
fluoresc
label
target
dna
measur
flow
cytometri
lowdens
maximum
adequ
diagnost
panel
assay
less
expens
highdens
format
fdaapprov
commerci
assay
xtag
respiratori
panel
flexibl
practic
format
clinic
use
multitud
clinic
applic
requir
care
valid
posit
fluoresc
threshold
analyt
userdefin
multiplexbeadbas
assay
adapt
miller
tang
uniqu
speci
present
mani
bodi
site
easili
grown
clinic
laboratori
turnbaugh
et
al
sever
recent
molecular
studi
clinic
sampl
cystic
fibrosi
patient
sibley
et
al
b
well
complex
abscess
versalov
demonstr
presenc
far
complex
microbi
flora
previous
found
use
phenotyp
method
classic
culturebas
method
like
given
clinic
microbiologist
skew
view
complex
microbi
commun
involv
infect
cultivat
pathogen
present
high
number
given
clinic
sampl
may
detect
report
petrosino
et
al
escherichia
coli
prototyp
gut
microorgan
organ
belong
cproteobacteria
phylum
entireti
repres
total
microbi
popul
human
intestin
hamadi
knight
e
coli
thought
domin
resid
human
gut
sole
readili
cultiv
vitro
far
greater
discriminatori
sensit
cultureindepend
approach
molecular
method
fundament
character
complex
humanassoci
microbi
commun
cultureindepend
molecular
technolog
typic
reli
either
direct
nucleic
acid
sequenc
electrophoresi
order
investig
commun
structur
commun
dynam
commun
behavior
roger
bruce
howev
revolut
highthroughput
sequenc
technolog
last
decad
allow
unpreced
data
output
order
magnitud
beyond
tradit
sangerbas
sequenc
fraction
cost
per
nucleotid
pallen
et
al
sever
high
throughput
sequenceindepend
communityprofil
approach
also
avail
includ
denatur
gradient
gel
electrophoresi
muyzer
et
al
autom
ribosom
intergen
spacer
analysi
fisher
triplett
termin
restrict
fragment
length
polymorph
trflp
analysi
liu
et
al
describ
trflp
deep
rrna
gene
sequenc
tool
profil
microbi
commun
trflp
approach
extens
use
profil
fungal
archeal
eubacteri
commun
comprehens
review
context
fingerprint
techniqu
past
schutt
et
al
tradit
use
profil
environment
commun
also
exploit
investig
microbi
commun
associ
oropharynx
gastrointestin
tract
lung
vagina
bodi
site
roger
et
al
coolen
et
al
sibley
et
al
yamamoto
et
al
jakobsson
et
al
techniqu
util
one
pcr
primer
label
fluoresc
dye
label
forward
revers
primer
improv
resolv
power
amplifi
univers
rrna
gene
bacteri
commun
interest
result
amplicon
digest
one
multipl
restrict
enzym
four
base
pair
recognit
sequenc
salt
primer
remov
rel
abund
termin
restrict
fragment
trf
resolv
polyacrylamid
gel
capillari
electrophoresi
result
data
repres
semiquantit
profil
domin
commun
member
trf
size
estim
refer
intern
size
standard
abund
express
either
peak
height
peak
area
trf
assign
oper
taxonom
unit
bin
accur
size
trf
challeng
due
fact
electrophoresi
mobil
influenc
sequenc
composit
kaplan
kitt
fluorophor
differ
electrophoresi
properti
tu
et
al
reason
comparison
profil
done
data
gener
fluorophor
also
known
discrep
true
experiment
determin
trf
exist
kaplan
kitt
trflp
inexpens
high
throughput
reproduc
effect
tool
character
dynam
chang
occur
humanassoci
microbi
commun
time
sibley
et
al
importantli
techniqu
best
suit
microbi
commun
low
intermedi
rich
popul
greater
distinct
organ
resolv
power
significantli
reduc
engebretson
moyer
like
pcrbase
assay
techniqu
suffer
amplif
bia
appropri
primer
select
essenti
howev
must
note
catchal
perfect
univers
primer
set
exist
commun
profil
marsh
et
al
program
avail
optim
primer
design
select
limit
incomplet
current
databas
collin
rocap
trflp
techniqu
suffer
fact
baselin
distinguish
signal
nois
necessarili
autom
peak
height
area
use
determin
threshold
sever
differ
strategi
employ
includ
use
fix
detect
threshold
fix
percentag
threshold
sait
et
al
variabl
percentag
threshold
osborn
et
al
use
correct
factor
dunbar
et
al
statist
method
abdo
et
al
advantag
disadvantag
schutt
et
al
webbas
silico
predict
tool
avail
microbi
identif
trflp
data
kent
et
al
shyu
et
al
tool
suffer
inher
experiment
issu
associ
trflp
enorm
size
unreli
mani
sequenc
current
databas
trflp
robust
silico
predict
corrobor
parallel
rrna
sequenc
either
clonebas
pyrosequenc
jakobsson
et
al
microbi
identif
data
base
sole
silico
predict
often
reliabl
confus
vast
number
possibl
organ
predict
trf
mani
suffer
uncultur
bacterium
phenomenon
relev
relationship
microbi
commun
assess
use
variou
tool
includ
princip
compon
analysi
multidimension
scale
selforgan
map
cluster
analysi
canon
correspond
analysi
schutt
et
al
certainli
trflp
provid
invalu
inexpens
data
quit
inform
respect
commun
dynam
particularli
commun
member
character
use
sophist
sequencingbas
approach
ident
specif
trf
determin
experiment
trflp
excel
tool
measur
divers
exist
amplicon
proceed
involv
commun
profil
experi
high
throughput
sequenc
nearli
differ
nextgener
sequenc
instrument
current
market
way
advantag
disadvantag
glenn
detail
discuss
regard
technic
aspect
technolog
far
beyond
scope
articl
excel
resourc
avail
martinez
nelson
metzker
sequenc
experi
rang
day
genom
analyz
iix
illumina
instrument
mere
two
hour
new
ion
torrent
instrument
life
technolog
singl
experi
gener
hundr
gigabas
data
glenn
sever
platform
wide
adopt
includ
roch
technolog
solexaillumina
platform
life
technolog
solid
platform
metzker
incred
amount
sequenc
throughput
provid
new
instrument
first
time
allow
deep
character
complex
microbi
commun
common
technolog
current
use
commun
profil
robust
chemistri
flx
titanium
instrument
gener
read
length
approxim
bp
total
mb
data
collect
h
run
upgrad
instrument
increas
read
length
bp
gener
mb
sequenc
per
h
run
sequenc
synthesi
approach
exploit
liber
pyrophosph
mediat
atpdepend
convers
luciferin
oxyluciferin
perhap
import
advanc
highthroughput
sequenc
respect
microbi
commun
profil
advent
barcod
pyrosequenc
allow
hundr
microbi
commun
sequenc
except
depth
simultan
barcod
effect
ad
sequenc
either
ligat
amplif
barcod
primer
sever
differ
barcod
strategi
gener
recommend
errorcorrect
errordetect
code
use
hamadi
knight
fortun
appear
differ
barcod
sequenc
significantli
alter
commun
analysi
replic
sampl
turnbaugh
et
al
earli
version
pyrosequenc
platform
shown
cost
effect
improv
diagnost
capabl
clinic
laboratori
particularli
organ
amen
biochem
test
luna
et
al
abil
gener
thousand
sequenc
read
hundr
sampl
run
take
less
day
attract
technolog
clinic
microbiolog
laboratori
fact
signific
advanc
made
adapt
highthroughput
pyrosequenc
technolog
clinic
laboratori
set
method
use
character
polymicrobi
natur
variou
clinic
entiti
includ
rhinosinus
surgic
wound
leg
ulcer
wolcott
et
al
wolcott
et
al
b
stephenson
et
al
nucleic
acid
extract
perhap
import
variabl
cultureindepend
approach
commun
profil
highthroughput
sequenc
except
morgan
et
al
sequenc
data
accur
correspond
concentr
commun
member
templat
dna
reflect
commun
composit
appear
variabl
commerci
avail
dna
extract
kit
bead
beat
hot
phenol
may
tremend
import
term
speci
presenceabs
concentr
commun
member
vari
significantli
extract
protocol
wu
et
al
highli
advis
rigor
evalu
valid
extract
method
ensur
data
accur
reflect
commun
composit
morgan
et
al
proceed
costli
sequenc
effort
caution
must
made
compar
experiment
data
gener
use
differ
extract
method
roger
bruce
number
sequenc
read
requir
clinic
specimen
depend
goal
studi
natur
microbi
commun
specimen
broad
brush
stroke
sought
rel
proport
phylalevel
shallow
sequenc
level
sequenc
per
sampl
would
suffic
ley
et
al
howev
depth
least
sequenc
per
sampl
one
confid
infer
frequenc
organ
abund
goal
complet
assess
microbi
constitu
sampl
much
deeper
sequenc
may
requir
often
even
possibl
practic
accomplish
task
estim
entir
run
million
read
use
singl
fecal
sampl
sequenc
five
cell
everi
billion
total
cell
would
sampl
hamadi
knight
goal
studi
detect
rare
pathogen
organ
target
pcr
approach
would
obvious
appropri
rrna
gene
approxim
kb
thu
larg
sequenc
pyrosequenc
reaction
surrog
hypervari
region
must
use
repres
nine
variabl
region
rrna
gene
vari
respect
util
microbi
identif
although
provid
lowest
error
rate
assign
taxonomi
wang
et
al
liu
et
al
current
standard
region
use
proxi
sequenc
recent
suggest
combin
might
provid
better
repres
character
kumar
et
al
region
appear
effect
univers
detect
pathogen
chakravorti
et
al
pcr
applic
primer
select
critic
primer
bia
alway
exist
commun
analysi
walter
et
al
howev
appreci
group
organ
might
disproport
repres
given
experiment
design
must
consid
metagenomicbas
sequenc
studi
done
parallel
commun
profil
organ
underrepres
pcr
bia
would
overlook
hamadi
knight
import
consider
nextgener
sequenc
technolog
error
rate
error
rate
consider
better
newer
gs
flx
instrument
accuraci
nextgener
pyrosequenc
compar
sanger
sequenc
error
rate
assembl
multipl
overlap
sequenc
read
use
correct
sequenc
error
possibl
commun
analysi
wherebi
everi
sequenc
read
repres
distinct
organ
commun
strategi
remov
sequenc
error
primer
sequenc
read
length
abnorm
data
set
significantli
improv
data
qualiti
huse
et
al
howev
care
must
still
taken
avoid
overestim
divers
rare
biospher
due
sequenc
error
quinc
et
al
reeder
knight
certainli
distinguish
low
frequenc
organ
sequenc
error
continu
area
intens
investig
gill
et
al
clinic
lab
interest
character
domin
commun
member
issu
associ
repres
rare
organ
would
issu
singleton
doubleton
read
could
ignor
petrosino
et
al
chimer
sequenc
also
gener
pcr
amplif
softwar
detect
sequenc
hybrid
exist
huber
et
al
edgar
et
al
haa
et
al
entir
effect
solut
deal
issu
larg
pyrosequenc
data
set
respect
rrna
sequenc
speci
genu
strainlevel
oper
taxonom
unit
defin
sequenc
ident
respect
promin
refer
databas
rrna
sequenc
data
includ
ribosom
databas
project
ii
rcpii
cole
et
al
greengen
desanti
et
al
arbsilva
pruess
et
al
howev
sequenc
often
use
clinic
laboratori
strainlevel
comparison
accur
techniqu
exist
clinic
laboratori
set
speci
level
case
strain
level
determin
critic
mani
pathogen
level
unequivoc
taxonom
assign
certain
instanc
difficult
bp
rrna
sequenc
pyrosequenc
often
reliabl
perspect
generalevel
confirm
specif
pathogen
realtim
pcr
character
strain
level
pfge
mlst
could
still
requir
current
comput
method
includ
unifrac
lozupon
knight
lozupon
et
al
son
schloss
handelsman
networkbas
comparison
ley
et
al
qiim
caporaso
et
al
significantli
improv
capac
analyz
larg
sequenc
data
set
hamadi
knight
nice
outlin
three
major
axe
ecolog
analysi
microbi
divers
commun
profil
data
alpha
vs
beta
divers
qualit
vs
quantit
analys
phylogen
vs
taxonbas
analys
hamadi
knight
type
analysi
employ
depend
entir
studi
design
clinic
laboratori
like
quantit
taxonbas
alpha
divers
metric
would
appropri
mean
diagnost
platform
would
measur
concentr
number
taxa
sampl
approach
treat
taxa
phylogenet
equival
entiti
addit
bacteri
commun
analysi
applic
highthroughput
sequenc
success
appli
sequenc
en
mass
total
dna
extract
microbi
commun
techniqu
refer
metagenom
impress
exampl
power
metagenom
date
sequenc
nearli
million
protein
code
gene
fecal
metagenom
deep
illuminabas
sequenc
qin
et
al
viral
pathogen
also
detect
directli
use
unbias
metagenom
approach
clinic
specimen
nakamura
et
al
outbreak
laboratori
test
initi
avail
identifi
viru
suggest
viru
may
circul
month
prior
identif
smith
et
al
metagenom
capabl
detect
influenza
viru
titer
near
limit
detect
rtpcr
grening
et
al
approach
could
play
import
role
rapid
detect
novel
pathogen
outbreak
acut
unexplain
ill
tang
chiu
alreadi
appli
diagnosi
lymphocyt
choriomening
viru
infect
transplant
recipi
palacio
et
al
addit
defin
etiolog
hemorrhag
fever
outbreak
towner
et
al
bries
et
al
bacteri
genom
sequenc
origin
extrem
labor
intens
time
consum
process
could
realist
becom
routin
tool
diagnost
epidemiolog
infect
control
pallen
et
al
refer
genom
exist
pyrosequenc
best
suit
de
novo
assembl
due
long
read
length
howev
platform
output
shorter
read
suitabl
scaffold
genom
avail
anthrax
attack
highlight
need
rapid
bacteri
genom
sequenc
pyrosequenc
technolog
shown
capabl
gener
draft
genom
bacillu
anthraci
could
use
assess
relev
genet
variant
less
h
recent
genom
e
coli
isol
implic
outbreak
europ
complet
sequenc
matter
hour
use
ion
torrent
platform
sequenc
bacteri
genom
longer
expens
estim
streptococc
genom
greater
coverag
cost
littl
us
vernet
et
al
whole
genom
sequenc
great
valu
epidemiolog
tool
recent
shown
superior
gold
standard
type
method
pfge
recent
canadian
listeria
monocytogen
outbreak
gilmour
et
al
similar
observ
made
multidrug
resist
acinetobact
baumannii
genom
wide
snp
analysi
extrem
discrimin
tool
studi
transmiss
event
could
adopt
clinic
laboratori
routin
outbreak
surveil
approach
gener
insight
perspect
epidemiolog
epidem
includ
import
commun
hospit
pathogen
methicillinresist
aureu
mrsa
harri
et
al
group
streptococcu
bere
et
al
addit
epidemiolog
applic
whole
genom
sequenc
also
effect
defin
antibiot
resist
determin
particular
pathogen
linezolid
resist
streptococcu
pneumonia
feng
et
al
technolog
exist
whole
genom
sequenc
singl
bacteri
cell
reli
multipl
displac
amplif
rodrigu
et
al
woyk
et
al
interest
see
approach
use
character
rare
enigmat
member
human
microbiom
sever
consider
sequenc
technolog
continu
significantli
improv
output
begin
transit
clinic
laboratori
real
need
streamlin
bioinformat
technician
clinic
laboratori
manipul
deep
sequenc
data
vast
amount
data
clinic
lab
would
produc
stagger
comput
infrastructur
would
requir
signific
improv
would
like
requir
take
advantag
distribut
comput
robust
server
network
petrosino
et
al
commun
profil
clinic
sampl
data
requir
indic
precis
clinic
relev
biomark
predict
pathogen
potenti
commun
effect
diseas
risk
manag
approach
commonplac
also
sever
technic
aspect
need
resolv
clear
clinic
applic
realiz
exampl
humanassoci
microbi
commun
contain
live
dead
bacteria
pcr
distinguish
two
sourc
nucleic
acid
protocol
develop
regard
excit
roger
et
al
nocker
camper
valid
high
throughput
sequenc
pipelin
requir
roger
bruce
although
larger
clinic
microbiolog
laboratori
increasingli
develop
molecular
assay
procedur
inhous
sever
barrier
exist
process
includ
rigor
valid
popul
test
qualiti
control
ensur
high
degre
autom
access
dedic
technologist
train
experienc
molecular
techniqu
access
capit
purchas
necessari
equip
expens
oper
molecular
microbiolog
laboratori
alongsid
phenotyp
culturedepend
test
howev
implement
cultureindepend
test
method
clinic
microbiolog
increas
next
decad
due
continu
develop
multiplex
method
realtim
pcr
liquid
suspens
beadbas
array
also
due
improv
futur
gener
sequenc
platform
increas
capac
read
length
reduc
cost
martinez
nelson
highthroughput
sequenc
technolog
appear
follow
moor
law
increasingli
potenti
applic
clinic
microbiolog
becom
appar
pallen
et
al
exampl
addit
bacteri
commun
analysi
deep
sequenc
appli
viral
commun
human
bodi
deep
sequenc
intrapati
hiv
viral
genom
reveal
intrigu
perspect
viral
resist
ecolog
wang
et
al
eriksson
et
al
le
et
al
simen
et
al
one
envis
next
gener
clinic
microbiologist
abil
perform
complex
analys
diagnost
epidemiolog
tool
routin
genom
wide
snp
high
throughput
commun
analysi
streamlin
metagenom
test
novel
pathogen
discoveri
within
reason
clinic
turnaround
time
howev
although
clinic
microbiolog
diagnost
techniqu
toolbox
potenti
significantli
increas
futur
unlik
cultureindepend
approach
entir
replac
cultiv
microb
import
strain
stock
phenotyp
inform
easili
infer
genotyp
data
medic
manag
infecti
diseas
evolv
need
altern
perspect
complex
chronic
infect
futur
molecular
approach
may
also
routin
use
simultan
investig
host
suscept
particular
type
infect
well
determin
pathogen
induc
phenotyp
chang
host
gene
express
microbi
infect
prognost
clinic
outcom
